MiniMed (MMED) EBIT Margin (2025 - 2026)
MiniMed (MMED) posted EBIT Margin of 0.59% for Q3 2026, up 105.34% quarter-over-quarter from 11.11% in Q2 2026, and up 239.0% YoY from 0.17% in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) EBIT Margin (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of EBIT Margin data on file, last reported at 0.59% in Q3 2026.
- For the quarter ending Q3 2026, EBIT Margin rose 239.0% year-over-year to 0.59%; the trailing twelve-month figure through Jul 2026 stood at 6.3% (changed N/A YoY), and the FY2026 full-year result was 6.13%, down 75.0% from the prior year.
- EBIT Margin was 0.59% for Q3 2026 at MiniMed, up from 11.11% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 3.06% in Q1 2025 to a low of 20.44% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 19.15% |
| 10 | MiniMed | 6.55 Bn | 6.34 Bn | 465.00 Mn | 0.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 0.59% |
| Apr 24, 2026 | -11.11% |
| Jan 23, 2026 | -12.66% |
| Apr 25, 2025 | -20.44% |
| Jan 24, 2025 | 3.06% |